利用CRISPR/Cas9技术进行Adcy3基因编辑小鼠模型的构建与鉴定
Construction and Confirmation of Adcy3 Gene Editing Mouse Model by CRISPR/Cas9 Technology
DOI: 10.12677/BP.2022.124030, PDF,    国家科技经费支持
作者: 杨 景, 周建丽, 赖娅娜*:南京医科大学医药实验动物中心,江苏 南京;曾文滔*:南京医科大学医药实验动物中心,江苏 南京;南京医科大学生殖医学国家重点实验室,江苏 南京
关键词: CRISPR/Cas9Adcy3融合蛋白 CRISPR/Cas9 Adcy3 Fusion Protein
摘要: 目的:利用CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR- As-sociated 9)技术构建成功Adcy3 (Cyclic Adenosine-3',5'-Monophosphate, cAMP)下游插入mCherry基因小鼠品系,为深入研究该基因的功能及相关疾病的治疗提供条件。方法:设计Adcy3基因sgRNA和mCherry供体,通过显微注射方式将Cas9mRNA、sgRNA和mCherry供体一同注射到C57BL/6小鼠受精卵中,获得Adcy3基因编辑小鼠。经过pcr鉴定和Sanger测序,对获得的子代小鼠,进行基因型的鉴定。结果:Adcy3基因编辑鼠构建成功,且能够通过正常繁育得到能够稳定遗传的子代小鼠。结论:建立了Adcy3-基因编辑小鼠模型,为小鼠体内Adcy3基因功能研究提供了新的小鼠模型。
Abstract: Objective: A mouse strain with mCherry gene inserted downstream of Adcy3 was successfully con-structed by CRISPR/Cas9 Technology, which provided a convenient animal models for in-depth study of the function of this gene and treatment of related diseases. Methods: Adcy3 gene sgRNA and mCherry donors were designed. Cas9 mRNA, sgRNA and mCherry donors were microinjected into the fertilized eggs of C57BL/6 mice to obtain Adcy3 gene editing mice. After pcr identification and Sanger sequencing, the obtained offspring mice were genotyped. Results: Adcy3 gene editing mice were successfully constructed, and could obtain stable offspring mice through normal breed-ing. Conclusions: It was confirmed that the Adcy3-mCherry mouse line was generated successfully, which provided a new mouse model for future studies of Adcy3 function research in vivo.
文章引用:杨景, 周建丽, 曾文滔, 赖娅娜. 利用CRISPR/Cas9技术进行Adcy3基因编辑小鼠模型的构建与鉴定[J]. 生物过程, 2022, 12(4): 257-263. https://doi.org/10.12677/BP.2022.124030

参考文献

[1] Defer, N., Best-Belpomme, M. and Hanoune, J. (2000) Tissue Specificity and Physiological Relevance of Various Isoforms of Adenylyl Cyclase. American Journal of Physiology-Renal Physiology, 279, 400-416. [Google Scholar] [CrossRef
[2] Bakalyar, H.A. and Reed, R.R. (1990) Identification of a Specialized Adenylyl Cyclase that May Mediate Odorant Detection. Science, 250, 1403-1406. [Google Scholar] [CrossRef] [PubMed]
[3] Yang, B., He, B., Abdel-Halim, S.M., Tibell, A., Brendel, M.D., Bretzel, R.G., Efendic, S. and Hillert, J. (1999) Molecular Cloning of a Full-Length cDNA for Human Type 3 Adenylyl Cyclase and Its Expression in Human Islets. Biochemical and Biophysical Research Communications, 254, 548-551. [Google Scholar] [CrossRef] [PubMed]
[4] Wong, S.T., Trinh, K., Hacker, B., et al. (2000) Disruption of the Type III Adenylyl Cyclase Gene Leads to Peripheral and Behavioral Anosmia in Transgenic Mice. Neuron, 27, 487-497. [Google Scholar] [CrossRef
[5] Siljee, J.E., Wang, Y., Bernard, A.A., et al. (2018). Subcel-lular Localization of MC4R with Adcy3 at Neuronal Primary Cilia Underlies a Common Pathway for Genetic Predisposi-tion to Obesity. Nature Genetics, 50, 180-185.[CrossRef] [PubMed]
[6] Saeed, S., Bonnefond, A., Tamanini, F., et al. (2018) Loss-of-Function Mutations in Adcy3 Cause Monogenic Severe Obesity. Nature Genetics, 50, 175-179. [Google Scholar] [CrossRef] [PubMed]
[7] Hong, S.H., Goh, S.H., Lee, S.J., et al. (2013) Upregulation of Adenylate Cyclase 3 (Adcy3) Increases the Tumorigenic Potential of Cells by Activating the CREB Pathway. Oncotarget, 4, 1791-1803. [Google Scholar] [CrossRef] [PubMed]
[8] Ran, F.A., Hsu, P.D., Lin, C.Y., et al. (2013) Double Nicking by RNA-guided CRISPR Cas9 for Enhanced Genome Editing Specificity. Cell, 154, 1380-1389. [Google Scholar] [CrossRef] [PubMed]
[9] Bassett, A.R., Tibbit, C., et al. (2013) Highly Efficient Targeted Mutagenesis of Drosophila with the CRISPR/Cas9 System. Cell Reports, 4, 220-228. [Google Scholar] [CrossRef] [PubMed]
[10] Hsu, P.D., Scott, D.A., Weinstein, J.A., et al. (2013) DNA Tar-geting Specificity of RNA-Guided Cas9 Nucleases. Nature Biotechnology, 31, 827-832. [Google Scholar] [CrossRef] [PubMed]
[11] Doench, J.G., Fusi, N., Sullender, M., et al. (2016) Optimized sgRNA De-sign to Maximize Activity and Minimize Off-Target Effects of CRISPR-Cas9. Nature Biotechnology, 34, 184-191. [Google Scholar] [CrossRef] [PubMed]
[12] Tycko, J., Wainberg, M., Marinov, G.K., et al. (2019) Mitigation of Off-Target Toxicity in CRISPR-Cas9 Screens for Essential Non-Coding Elements. Nature Communications, 10, Article No. 4063. [Google Scholar] [CrossRef] [PubMed]
[13] Paix, A., Folkmann, A., Goldman, D.H., et al. (2017) Precision Genome Editing Using Synthesis-Dependent Repair of Cas9-Induced DNA Breaks. Proceedings of the National Acade-my of Sciences, 114, E10745-E10754. [Google Scholar] [CrossRef] [PubMed]